Filter Results :

Your search for Lymphoma returned 125 reports

Sort by


Lymphoma Treatment Drugs Markets in China

15 Aug 2015  |  Published by:  Asia Market Info and Dev Co.
China's demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports &...

$ 4,000.00

Read More

Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

30 Jun 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Non-Hodgkin Lymphoma, complete with comparative analysis at var...

$ 2,000.00

Read More

Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

24 Jun 2015  |  Published by:  Global Markets Direct
Summary‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Diffuse Large B-Cell Lymphoma, complete with comparative analysis at v...

$ 2,000.00

Read More

Follicular Lymphoma - Pipeline Review, H1 2015

24 Jun 2015  |  Published by:  Global Markets Direct
Summary‘Follicular Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Follicular Lymphoma, complete with comparative analysis at various stages, therapeutics as...

$ 2,000.00

Read More

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

27 May 2015  |  Published by:  GlobalData
SummaryThe Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare organization. The organization provides funding to blood cancer research, and offers education and patient services. It provides services, such as fund raising, patient services, health education, policy advocacy and medical research...

$ 250.00

Read More

Burkitt Lymphoma - Pipeline Review, H1 2015

20 May 2015  |  Published by:  Global Markets Direct
Summary‘Burkitt Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Burkitt Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Burkitt Lymphoma, complete with comparative analysis at various stages, therapeutics assessment ...

$ 2,000.00

Read More

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Mantle Cell Lymphoma-API Insights, 2015,report provides Mantle Cell Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by wor...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Peripheral T-Cell Lymphomas (PTCL)-API Insights, 2015,report provides Peripheral T-Cell Lymphomas (PTCL) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF)...

$ 1,250.00

Read More

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, T-Cell Lymphomas-API Insights, 2015,report provides T-Cell Lymphomas drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Non-Hodgkin Lymphoma-API Insights, 2015,report provides Non-Hodgkin Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by wor...

$ 1,250.00

Read More

Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acute Lymphoblastic Lymphoma-API Insights, 2015,report provides Acute Lymphoblastic Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe ...

$ 1,250.00

Read More

Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Follicular Lymphoma-API Insights, 2015,report provides Follicular Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by world...

$ 1,250.00

Read More

Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Burkitt Lymphoma-API Insights, 2015,report provides Burkitt Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Cutaneous T-Cell Lymphoma-API Insights, 2015,report provides Cutaneous T-Cell Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF fi...

$ 1,250.00

Read More

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Hodgkin Lymphoma-API Insights, 2015,report provides Hodgkin Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More
Total 125 records.